MiProstate - Information Hub for the Prostate Cancer Care Flow
NCT ID: NCT05239377
Last Updated: 2022-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1329 participants
OBSERVATIONAL
2017-02-21
2021-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations
NCT03835533
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
NCT06039371
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
NCT03532217
PROSAIC-DS Study (PROState AI in Cancer - Decision Support)
NCT05355727
CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT01881867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baseline
Pre-prostatectomy conferences conducted without the use of digital support
No interventions assigned to this group
ISPM -MiProstate
Pre-prostatectomy conferences conducted with the use of digital support (ISPM- MiProstate)
IntelliSpace Precision Medicine Multidisciplinary Team Orchestrator
Digital decision support
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IntelliSpace Precision Medicine Multidisciplinary Team Orchestrator
Digital decision support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philips Electronics Nederland B.V. acting through Philips CTO organization
INDUSTRY
Karolinska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olof Akre
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olof Akre, MD,Professor
Role: PRINCIPAL_INVESTIGATOR
Karolinska University Hospital, Dept of Pelvic Cancer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska University Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MiProstate
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.